Serum 25-hydroxycalciferol concentrations in normal subjects and in haemodialysed patients with chronic renal failure

Area of Science:

• Nephrology
• Endocrinology
• Biochemistry

Background:

• Chronic renal failure (CRF) can affect vitamin D metabolism.
• Hemodialysis is a common treatment for end-stage renal disease.
• Serum 25-hydroxyvitamin D3 (25-OHD3) is a key indicator of vitamin D status.

Purpose of the Study:

• To compare serum 25-OHD3 concentrations in patients with CRF undergoing hemodialysis versus healthy individuals.
• To investigate the impact of chronic renal failure on vitamin D status.

Main Methods:

• Serum samples were collected from 16 healthy subjects and 12 patients with CRF undergoing hemodialysis.
• Serum 25-OHD3 concentrations were quantified using a standardized assay.
• Statistical analysis was performed to compare mean values between the two groups.

Main Results:

• The mean serum 25-OHD3 level in normal subjects was 27.8 +/- 17.8 ng/ml.
• The mean serum 25-OHD3 level in hemodialysis patients was 23.9 +/- 12 ng/ml.
• The difference in mean serum 25-OHD3 levels between the groups was not statistically significant.

Conclusions:

• Serum 25-OHD3 concentrations do not significantly differ between patients with chronic renal failure undergoing hemodialysis and normal subjects.
• Chronic renal failure and hemodialysis treatment may not substantially alter overall vitamin D status as measured by 25-OHD3.
• Further research may explore other vitamin D metabolites or factors influencing vitamin D status in CRF.